Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise

Can Fisher & Paykel Healthcare justify Nvidia-level premium amid tariff noise
Fisher & Paykel Healthcare's Lewis Gradon addressed shareholders at the company's AGM. (Image: Jacques Steenkamp)
Stock & Trade
Most markets have them - market darlings which are treated as all but sacrosanct investments, whose shares are placed on a pedestal and priced far above multiples of their competitors. Overowned and overbought, with fundamentals that are rarely subject to strict scrutiny.Does Fisher & Paykel Healthcare fall into this camp?Get up to date fast. Join BusinessDesk's WhatsApp channel.Its shares trade 58 times trailing earnings – nosebleed territory – which puts it at a significant premium to other blue-chip medical technolog...

More Markets

Nvidia earnings boost markets, NZ sharemarket closes up
Markets Market Close

Nvidia earnings boost markets, NZ sharemarket closes up

The S&P/NZX 50 Index closed up 0.84% or 112.502 points. 

Jade Software to acquire Contec Group
Markets

Jade Software to acquire Contec Group

The acquisition adds Contec’s Madcap software to Jade’s portfolio.

AFT forges ahead with China iron injectable deal
Markets

AFT forges ahead with China iron injectable deal

Oldest iron products in Aussie are booming, while new iron injectable gets China boost.

Meridian says hydro is key to energy security and affordability
Markets

Meridian says hydro is key to energy security and affordability

Meridian says it has learnt lessons from winter 2024.